India is set to implement a mandatory registration for printed pharmaceutical packaging manufacturers to combat counterfeit drugs. This mov...

The launch follows marketing authorisation from the Central Drugs Standard Control Organisation (CDSCO) for patients with locally advanced ...

Certified nutrition coach Vanishka Khurana achieved a remarkable 40 kg weight loss over three years by embracing consistency and a balanced...

Celebrity trainer Siddhartha Singh, who trains Tamannaah Bhatia, warns that Ozempic's real challenge begins post-weight loss. He stresses t...

Zerodha CEO Nithin Kamath lost a ₹2.5 lakh fitness bet to employee Rohit Agarwala, who successfully shed 30 kg in a year. Agarwala's transf...

Trump's investment accounts saw thousands of trades totaling hundreds of millions of dollars between January and March. This feverish activ...

A young woman achieved significant weight loss without gyms or crash diets. She focused on walking 10,000 steps daily and eating home-cooke...

Indian drugmaker Biocon aims to be the world's top insulin supplier within five years, capitalising on growing demand as major pharmaceutic...

Global drug companies are boosting U.S. production and stockpiling medicines. This is a response to potential tariffs on branded drugs. Com...

Electronics Mart India is diversifying its store presence beyond Hyderabad due to concerns about potential AI-driven job losses impacting c...

A new drug for Alzheimer's, donanemab, has arrived in India. It aims to slow the disease's progression by clearing brain plaques. While off...

India's market for cheaper anti-obesity drugs has surged tenfold. While demand is high, especially among those with diabetes, concerns abou...

The benchmark snapped a four-day losing streak on Thursday, as ⁠investors digested the European Central Bank's rate hike and largely looked...

Britain's medicine regulator has approved Novo Nordisk's weight-loss pill. This makes the UK the first European market for the oral treatme...

U.S. stocks largely rose Monday, with the Nasdaq and chipmakers leading the gains as investors sought bargains after Friday's selloff. Reli...

Lilly presented full data from two retatrutide trials, one in treatment naive type 2 diabetes patients and another in patients with obesity...

Eli Lilly presented trial results for its new obesity drug retatrutide. The drug significantly reduced sleep apnea severity and knee osteoa...